Descriptive Analysis of Surgeries in Patients With Multiple Osteochondromas
CHIROS
Analisi Descrittiva di Chirurgie in Pazienti Con Osteocondromi Multipli
1 other identifier
observational
300
1 country
1
Brief Summary
Multiple Osteochondromas (MO), also known as Multiple Cartilaginous Exostoses, is an autosomal dominant skeletal disorder with an incidence of approximately 1 in 50,000 in Western populations. Most cases are associated with pathogenic variants in the EXT1 and EXT2 genes, which lead to a systemic reduction of heparan sulfate, causing abnormalities in bone growth and other physiological processes. Symptoms typically appear in childhood and include the development of bony protrusions often associated with pain due to compression of muscles and nerves. Patients are generally shorter than average and may experience dislocations, subluxations, reduced motor function, and skeletal deformities such as genu valgum, limb asymmetry, and scoliosis. The most severe complication is malignant transformation into chondrosarcoma, occurring in 0.5-5% of adult patients. Diagnosis is mainly based on imaging techniques (X-ray, CT, MRI, ultrasound) and is confirmed by the presence of at least two osteochondromas after excluding other conditions. Following diagnosis, patients or their caregivers often raise questions regarding disease progression, the number and type of surgical interventions required, and differences between pediatric and adult surgical approaches. This retrospective observational cohort study aims to characterize the number and types of surgical procedures performed in MO patients at a European referral center, the Rizzoli Orthopaedic Institute.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 23, 2025
CompletedFirst Submitted
Initial submission to the registry
April 22, 2026
CompletedFirst Posted
Study publicly available on registry
April 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2028
April 29, 2026
April 1, 2026
2.9 years
April 22, 2026
April 22, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Number and type of surgeries for Multiple Osteochondromas
3 years
Secondary Outcomes (2)
Definition of a score based on osteochondromas location, severity, and deformity/limitations
3 years
Descriptive indexes of patients age and number of malignant transformations of osteochondromas
3 years
Interventions
Surgeries for osteochondromas performed at the Rizzoli Orthopedic Institute
Eligibility Criteria
Patients with multiple osteochondromas who underwent surgery at the Rizzoli Orthopedic Institute
You may qualify if:
- Patients diagnosed with multiple osteochondromas who underwent surgery at the IOR between January 1, 2012, and February 28, 2025.
- Patients of both sexes, regardless of age.
You may not qualify if:
- \- Patients with conditions that are part of the differential diagnosis for the condition under study, such as enchondromatosis and solitary exostosis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Istituto Ortopedico Rizzoli
Bologna, Bologna, 40136, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Marina Mordenti
Study Record Dates
First Submitted
April 22, 2026
First Posted
April 29, 2026
Study Start
October 23, 2025
Primary Completion (Estimated)
October 1, 2028
Study Completion (Estimated)
October 1, 2028
Last Updated
April 29, 2026
Record last verified: 2026-04